Phio Pharmaceuticals Corp. (PHIO)
1.13
+0.03
(+2.73%)
USD |
NASDAQ |
Sep 02, 16:00
1.14
+0.01
(+0.88%)
After-Hours: 20:00
Phio Pharmaceuticals Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.003M |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -0.007M |
| June 30, 2025 | -0.003M |
| March 31, 2025 | -0.002M |
| December 31, 2024 | 0.008M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.005M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.007M |
| June 30, 2022 | -0.01M |
| March 31, 2022 | -0.104M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.03M |
| June 30, 2021 | -0.015M |
| March 31, 2021 | -0.006M |
| December 31, 2020 | -0.001M |
| September 30, 2020 | -0.008M |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.01M |
| December 31, 2019 | 0.005M |
| September 30, 2019 | -0.061M |
| June 30, 2019 | -0.015M |
| March 31, 2019 | -0.001M |
| December 31, 2018 | -0.005M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.015M |
| June 30, 2017 | -0.186M |
| March 31, 2017 | 0.098M |
| December 31, 2016 | 1.848M |
| September 30, 2016 | -0.002M |
| June 30, 2016 | 1.50M |
| March 31, 2016 | 2.00M |
| December 31, 2015 | 2.482M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -8.031M |
| March 31, 2015 | -0.008M |
| December 31, 2014 | 4.991M |
| September 30, 2014 | -5.015M |
| June 30, 2014 | 2.941M |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Imunon, Inc. | -0.0691M |
| Agenus, Inc. | 0.267M |
| Amgen, Inc. | -569.00M |
| Anika Therapeutics, Inc. | -1.28M |
| BioCryst Pharmaceuticals, Inc. | -110.15M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.035M |
| Free Cash Flow | -12.21M |
| Free Cash Flow Per Share (Quarterly) | -0.3473 |
| Free Cash Flow to Equity (Quarterly) | -4.035M |
| Free Cash Flow to Firm (Quarterly) | -4.035M |
| Free Cash Flow Yield | -107.2% |